The current state of Natural Capsules' stock, its core fundamentals, and its valuation; insights for potential investors to make an informed decision. Briefing Since peaking at ₹638.95 per share on 9 Sep. 2022, the stock of Natural Capsules has been in a long decline during which it lost 50 per cent in value over one-and-half … Continue reading Revisiting Natural Capsules: Is It Worth the Risk Now?
Category: Investment Analysis
How to Beat the Market
Identify High-Risk Stocks That Are More Likely to Get Re-Rated, and for that, Focus on Core Fundamentals. “In the short run, the market is a voting machine. In the long run, it is a weighing machine.” Benjamin Graham “Beating the Market”: earning an investment return greater than the return of benchmark indices such as Sensex, … Continue reading How to Beat the Market
Is Ador Fontech Stock a Buy or Sell?
Analysing ADFL's Financials and Valuation to Determine its Investment Prospects The stock of Ador Fontech trades at ₹140 per share – 11 per cent off its all-time high of ₹157.20 per share attained on 5 Jan. 2024. The stock has delivered superior returns over the past five years – 21.16 per cent annually. On a … Continue reading Is Ador Fontech Stock a Buy or Sell?
Gandhi Special Tubes: No Tailwinds, No Headwinds Either
"Examining the Risks and Rewards of Investing in the Stock of a Niche Manufacturing Company" Firstly, for the benefit of the uninitiated, a brief introduction to the stock: Gandhi Special Tubes principally manufactures a niche product – small-diameter seamless steel tubes that are supplied to the original equipment manufacturers (OEMs) in the automotive, farm equipment, … Continue reading Gandhi Special Tubes: No Tailwinds, No Headwinds Either
Star Cement: Is it Worth Investing Now?
Scrutinising Star Cement's Recent Outstanding Performance, Current Valuation, and Investment Prospects The stock of Star Cement gained 10.54 per cent on 22 Mar. 2024 – and closed the day at ₹232 per share – making a new all-time high. The stock now trades at ₹230.60 per share. One-and-a-half years ago, in Sep. 2022, it was … Continue reading Star Cement: Is it Worth Investing Now?
Significance of Interpreting Market Price Action
For successful investing… the market price movement should be given the most consideration… often greater than fundamentals and valuation… The phrase ‘market prices reflect everything’ means that, at any moment, a stock’s price reflects all information concerning its business prospect – and every price change then on reflects a change in those prospects. However, this … Continue reading Significance of Interpreting Market Price Action
Gold Prices: An Ominous Aura
Stubborn resistance to oxidation, unusual density, and ready malleability – these simple natural attributes explain all there is to the romance of gold. Peter L. Bernstein, The Power of Gold: The History of an Obsession Gold Prices and Market Foreknowing Analysing the Implications of Recent Gold Price Spikes and What They Could Mean for Investors. … Continue reading Gold Prices: An Ominous Aura
L G Balakrishnan, Oriental Carbon, Associated Alcohols
This post discusses the investment prospects of L G Balakrishnan & Bros., Oriental Carbon & Chemicals, and Associated Alcohols & Breweries. Convergence The Past One-year Performance of L G Balakrishnan & Bros. illustrates the Importance of Margin of Safety in Stock Investing In April 2023, when we previously discussed it, we were bullish on the … Continue reading L G Balakrishnan, Oriental Carbon, Associated Alcohols
Has the Market Run Too Far Ahead?
The Indian stock market is currently in a bull market that is more than twenty years old. It began in 2003 and since then the Nifty50 index has multiplied eleven times – an annualised return of 13 percent. However, the rise in stock prices wasn’t smooth and linear. There were occasional price corrections; two of … Continue reading Has the Market Run Too Far Ahead?
Stock Musings – Lincoln Pharma, Dynemic Products, Pakka
LINCOLN PHARMA The stock of Lincoln Pharma is up 90 percent in the last year, a commendable feat considering its low earnings growth, mediocre working capital management, and sluggish capital allocation. However, it is not a poor-quality stock. The stock has good fundamentals, such as a debt-free balance sheet and a high and stable gross … Continue reading Stock Musings – Lincoln Pharma, Dynemic Products, Pakka









